ES552052A0 - Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida. - Google Patents

Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.

Info

Publication number
ES552052A0
ES552052A0 ES552052A ES552052A ES552052A0 ES 552052 A0 ES552052 A0 ES 552052A0 ES 552052 A ES552052 A ES 552052A ES 552052 A ES552052 A ES 552052A ES 552052 A0 ES552052 A0 ES 552052A0
Authority
ES
Spain
Prior art keywords
androstendiona
derivatives
substituted
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES552052A
Other languages
English (en)
Other versions
ES8706165A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of ES8706165A1 publication Critical patent/ES8706165A1/es
Publication of ES552052A0 publication Critical patent/ES552052A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides
ES552052A 1985-02-15 1986-02-14 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida. Expired ES8706165A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503940A GB8503940D0 (en) 1985-02-15 1985-02-15 4-substituted androstendione derivatives

Publications (2)

Publication Number Publication Date
ES8706165A1 ES8706165A1 (es) 1987-06-01
ES552052A0 true ES552052A0 (es) 1987-06-01

Family

ID=10574550

Family Applications (2)

Application Number Title Priority Date Filing Date
ES552052A Expired ES8706165A1 (es) 1985-02-15 1986-02-14 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
ES557215A Expired ES8708235A1 (es) 1985-02-15 1986-11-20 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557215A Expired ES8708235A1 (es) 1985-02-15 1986-11-20 Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida

Country Status (28)

Country Link
US (1) US4757061A (es)
JP (1) JPS61189295A (es)
KR (1) KR930005994B1 (es)
AT (1) AT396239B (es)
AU (1) AU577667B2 (es)
BE (1) BE904226A (es)
CA (1) CA1319362C (es)
CH (1) CH669199A5 (es)
CZ (1) CZ413691A3 (es)
DE (1) DE3604179A1 (es)
DK (1) DK167221B1 (es)
ES (2) ES8706165A1 (es)
FI (1) FI84272C (es)
FR (1) FR2577556B1 (es)
GB (2) GB8503940D0 (es)
GR (1) GR860430B (es)
HK (1) HK94090A (es)
HU (1) HU194909B (es)
IE (1) IE58864B1 (es)
IT (1) IT1190335B (es)
MY (1) MY102038A (es)
NL (1) NL8600383A (es)
NZ (1) NZ215163A (es)
PT (1) PT82030B (es)
SE (2) SE8600668L (es)
SG (1) SG80890G (es)
SU (1) SU1574178A3 (es)
ZA (1) ZA861118B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3711772A1 (de) * 1987-04-08 1988-10-27 Schering Ag 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
ATE269066T1 (de) * 1989-07-07 2004-07-15 Endorech Inc Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie
NZ239142A (en) * 1990-08-01 1994-05-26 Merrell Dow Pharma 4-amino-delta-4-steroids; preparatory processes and pharmaceutical compositions
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
US5318961A (en) * 1990-08-01 1994-06-07 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
NZ239141A (en) * 1990-08-01 1994-04-27 Merrell Dow Pharma 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5189032A (en) * 1991-03-19 1993-02-23 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
AU652038B2 (en) * 1991-03-28 1994-08-11 Teikoku Hormone Mfg. Co., Ltd. Novel oxa- or azasteroid derivative
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9111260D0 (en) * 1991-05-24 1991-07-17 Erba Carlo Spa Process for the preparation of 4-amino-unsaturated androstanedione derivatives
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
PL176114B1 (pl) * 1992-09-30 1999-04-30 Teikoku Hormone Mfg Co Ltd Nowe związki 7-podstawione oksasteroidowe
CA2118317A1 (en) * 1993-02-18 1994-09-01 Pharmacia S.P.A. Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB2284605A (en) * 1993-12-09 1995-06-14 Erba Carlo Spa 6-or 7-substituted 4-aminoandrostadienone derivatives
AU686793B2 (en) * 1994-05-02 1998-02-12 Merrell Pharmaceuticals Inc. Process for the preparation of 4-amino- 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DE1203768B (de) * 1962-02-01 1965-10-28 Merck Ag E Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Testosteronreiheund Saeureadditionssalzen derselben
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
DE1668690C3 (de) * 1968-02-29 1978-09-14 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Androstan-Pregnan- und Cholestanreihe
US3780070A (en) * 1972-09-21 1973-12-18 Schering Corp 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation
CA1154008A (en) * 1979-05-02 1983-09-20 Thomas R. Blohm STEROID 5.alpha.-REDUCTASE INHIBITORS

Also Published As

Publication number Publication date
CZ413691A3 (en) 1994-03-16
SE468515B (sv) 1993-02-01
PT82030B (pt) 1988-07-01
GB2171100B (en) 1988-11-30
SU1574178A3 (ru) 1990-06-23
MY102038A (en) 1992-02-29
FI84272B (fi) 1991-07-31
KR860006485A (ko) 1986-09-11
JPH0469638B2 (es) 1992-11-06
HUT40454A (en) 1986-12-28
US4757061A (en) 1988-07-12
GB8603265D0 (en) 1986-03-19
DK71486D0 (da) 1986-02-14
IT1190335B (it) 1988-02-16
ES8706165A1 (es) 1987-06-01
FI860672A0 (fi) 1986-02-13
IE58864B1 (en) 1993-11-17
CH669199A5 (de) 1989-02-28
FR2577556B1 (fr) 1988-01-08
KR930005994B1 (ko) 1993-07-01
NZ215163A (en) 1988-02-29
SE8600668L (sv) 1986-08-16
IT8619361A0 (it) 1986-02-11
ZA861118B (en) 1986-10-29
DE3604179A1 (de) 1986-08-21
FR2577556A1 (fr) 1986-08-22
AU5343386A (en) 1986-08-21
NL8600383A (nl) 1986-09-01
CA1319362C (en) 1993-06-22
SG80890G (en) 1990-11-23
SE8600668D0 (sv) 1986-02-14
ES557215A0 (es) 1987-10-01
GB2171100A (en) 1986-08-20
BE904226A (fr) 1986-08-14
JPS61189295A (ja) 1986-08-22
IT8619361A1 (it) 1987-08-11
PT82030A (en) 1986-03-01
ES8708235A1 (es) 1987-10-01
GR860430B (en) 1986-06-12
DK167221B1 (da) 1993-09-20
DK71486A (da) 1986-08-16
AT396239B (de) 1993-07-26
GB8503940D0 (en) 1985-03-20
IE860413L (en) 1986-08-15
FI84272C (fi) 1991-11-11
FI860672A (fi) 1986-08-16
AU577667B2 (en) 1988-09-29
HU194909B (en) 1988-03-28
HK94090A (en) 1990-11-23
ATA38886A (de) 1992-11-15

Similar Documents

Publication Publication Date Title
ES552052A0 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES552502A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiazolidina.
ES539281A0 (es) Un procedimiento para la preparacion de derivados de piperidina.
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES556145A0 (es) Un procedimiento para la preparacion de nuevos derivados de piperazina.
ES556467A0 (es) Un procedimiento para la preparacion de derivados de furanona.
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES552297A0 (es) Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES550819A0 (es) Un procedimiento para preparar nuevos derivados de cefem.
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES555369A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato.
ES557397A0 (es) Un procedimiento para preparar derivados arilicos de diemanidas.
ES550829A0 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES557839A0 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos.
ES555723A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES552241A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirazolopiridinas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000403